| scholarly article | Q13442814 |
| P2093 | author name string | Randi J Hagerman | |
| Kyoungmi Kim | |||
| Andreea L Seritan | |||
| Ian Benjamin | |||
| Ioana Seritan | |||
| P2860 | cites work | Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia | Q37152104 |
| New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS) | Q37154956 | ||
| Obstructive sleep apnea and neurocognitive performance: the role of cortisol | Q37530601 | ||
| Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS. | Q37663133 | ||
| Age-dependent structural connectivity effects in fragile x premutation | Q37691745 | ||
| Risk factors and preventive interventions for Alzheimer disease: state of the science | Q37873674 | ||
| Parkinson's disease dementia: Diagnostic criteria and risk factor review | Q38404712 | ||
| Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment | Q40372780 | ||
| Interaction between genetic and environmental risk factors for Alzheimer's disease: a reanalysis of case-control studies | Q40504983 | ||
| Relationship between sleep-disordered breathing and metabolic syndrome after adjustment with cardiovascular risk factors | Q41142988 | ||
| GRAND ROUNDS: an atypical progressive dementia in a male carrier of the fragile X premutation: an example of fragile X-associated tremor/ataxia syndrome | Q43979962 | ||
| Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation. | Q44279873 | ||
| Fragile X premutation in a woman with cognitive impairment, tremor, and history of premature ovarian failure | Q44373619 | ||
| Changes in cognitive functioning following treatment of late-life depression | Q44944122 | ||
| High apolipoprotein E4 allele frequency in FXTAS patients. | Q45106065 | ||
| Mood and anxiety disorders in females with the FMR1 premutation | Q45582526 | ||
| Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). | Q46007399 | ||
| CGG repeat length correlates with age of onset of motor signs of the fragile X-associated tremor/ataxia syndrome (FXTAS). | Q46218699 | ||
| Dementia with mood symptoms in a fragile X premutation carrier with the fragile X-associated tremor/ataxia syndrome: clinical intervention with donepezil and venlafaxine | Q46376590 | ||
| Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study | Q46827956 | ||
| Atypical clinical course of FXTAS: rapidly progressive dementia as the major symptom | Q48161305 | ||
| Fragile X dementia Parkinsonism Syndrome (FXDPS). | Q48267383 | ||
| FXTAS: new insights and the need for revised diagnostic criteria | Q48331490 | ||
| Progression of tremor and ataxia in male carriers of the FMR1 premutation | Q48354732 | ||
| Motor and mental dysfunction in mother-daughter transmitted FXTAS. | Q50267098 | ||
| Impairment of executive cognitive functioning in males with fragile X-associated tremor/ataxia syndrome | Q50277439 | ||
| Impairment in the cognitive functioning of men with fragile X-associated tremor/ataxia syndrome (FXTAS). | Q50278350 | ||
| Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome | Q50278365 | ||
| Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia | Q50278933 | ||
| A neuropsychological investigation of male premutation carriers of fragile X syndrome | Q50282888 | ||
| Fragile X associated tremor/ataxia syndrome (FXTAS) with dementia in a female harbouring FMR1 premutation. | Q51701945 | ||
| Age-dependent cognitive changes in carriers of the fragile X syndrome. | Q51890929 | ||
| Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment. | Q53350279 | ||
| Reduced telomere length in older men with premutation alleles of the fragile X mental retardation 1 gene. | Q55129350 | ||
| Expanded clinical phenotype of women with the FMR1 premutation. | Q55420262 | ||
| Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS). | Q55497214 | ||
| Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach | Q55980548 | ||
| The course of geriatric depression with "reversible dementia": a controlled study | Q58391689 | ||
| Conversion disorder in women with the FMR1 premutation | Q84751197 | ||
| Untreated Depression and Hippocampal Volume Loss | Q22306281 | ||
| Fragile X-associated tremor/ataxia syndrome | Q26852667 | ||
| Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles. | Q33637452 | ||
| Lifetime prevalence of mood and anxiety disorders in fragile X premutation carriers | Q33684243 | ||
| Huntington's disease: from molecular pathogenesis to clinical treatment | Q33773061 | ||
| Abnormal N400 word repetition effects in fragile X-associated tremor/ataxia syndrome | Q33808428 | ||
| Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates | Q33905067 | ||
| Sleep apnea in fragile X premutation carriers with and without FXTAS. | Q33943666 | ||
| Dementia in fragile X-associated tremor/ataxia syndrome (FXTAS): comparison with Alzheimer's disease | Q33967902 | ||
| Lifespan changes in working memory in fragile X premutation males | Q34154343 | ||
| Predictors of dementia in Parkinson disease: a prospective cohort study | Q34269001 | ||
| ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI. | Q34324687 | ||
| Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families. | Q34327177 | ||
| Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression | Q34461748 | ||
| Neuropsychological findings from older premutation carrier males and their noncarrier siblings from families with fragile X syndrome | Q34917080 | ||
| Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial. | Q34977377 | ||
| COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS. | Q35006611 | ||
| PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS. | Q35006614 | ||
| Selective executive markers of at-risk profiles associated with the fragile X premutation | Q35173554 | ||
| Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers | Q35248803 | ||
| Assessment of patient and caregiver needs in fragile X-associated tremor/ataxia syndrome by utilizing Q-sort methodology | Q35293962 | ||
| Functional status of men with the fragile X premutation, with and without the tremor/ataxia syndrome (FXTAS). | Q35551515 | ||
| Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women | Q36694340 | ||
| The projected effect of risk factor reduction on Alzheimer's disease prevalence | Q36825862 | ||
| Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems | Q36897434 | ||
| Late-life depression, mild cognitive impairment, and dementia | Q36960564 | ||
| P921 | main subject | fragile X-associated tremor/ataxia syndrome | Q1440436 |
| cognitive dysfunction | Q57859955 | ||
| P577 | publication date | 2016-09-19 | |
| P1433 | published in | Journal of Geriatric Psychiatry and Neurology | Q6295256 |
| P1476 | title | Risk Factors for Cognitive Impairment in Fragile X-Associated Tremor/Ataxia Syndrome |
| Q41684295 | Fragile X-Associated Diminished Ovarian Reserve and Primary Ovarian Insufficiency from Molecular Mechanisms to Clinical Manifestations |
| Q89695595 | Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS) |
| Q91918711 | [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment] |
Search more.